Displaying all 2 publications

  1. Chan KY, Lau CL, Adeeb SM, Somasundaram S, Nasir-Zahari M
    Plast Reconstr Surg, 2005 Sep 15;116(4):1013-20; discussion 1021-2.
    PMID: 16163087
    BACKGROUND: Hypertrophic scarring caused by sternotomy is prevalent among Asians. The effectiveness of silicone gel in scar prevention may influence the decision of surgeons and patients regarding its routine use during the postoperative period.

    METHODS: The authors conducted a randomized, placebo-controlled, double-blind, prospective clinical trial. The susceptibility to scar development varied among patients; therefore, sternal wounds were divided into the upper half and the lower half. Two types of coded gel prepared by an independent pharmacist were used on either half. Thus, selection and assessment biases and confounders were eliminated.

    RESULTS: One hundred wounds in 50 patients were randomized into two arms, 50 control and 50 silicone gels. The median age was 61 years and there were 34 men and 16 women. Ethnic distribution was 28 Malays, 18 Chinese, and four Indians. No side effect caused by the silicone gel was noted. Ninety-eight percent of patients had moderate to good compliance. The incidence of sternotomy scar was 94 percent. At the third month postoperatively, the silicone gel wounds were scored lower when compared with the control wounds. The differences were statistically significant in all parameters, including pigmentation (p = 0.02), vascularity (p = 0.001), pliability (p = 0.001), height (p = 0.001), pain (p = 0.001), and itchiness (p = 0.02).

    CONCLUSIONS: The effect of silicone gel in prevention of hypertrophic scar development in sternotomy wounds is promising. There are no side effects and patients' compliance is satisfactory. This study may popularize the use of silicone gel in all types of surgery to minimize the formation of hypertrophic scars in the early postoperative period.

    Matched MeSH terms: Silicone Gels/therapeutic use*
  2. Wei S, Ching YC, Chuah CH
    Carbohydr Polym, 2020 Mar 01;231:115744.
    PMID: 31888854 DOI: 10.1016/j.carbpol.2019.115744
    Chitosan with abundant functional groups is regarded as important ingredients for preparing aerogel materials in life science. The biocompatibility and biodegradability of chitosan aerogels, coupled to the variety of chemical functionalities they include, result in them promising carriers for drug delivery. Moreover, chitosan aerogels as drug delivery vehicles can offer improved drug bioavailability and drug loading capacity due to their highly porous network, considerably large specific surface area and polycationic feature. The major focus of this review lies in preparation methods of chitosan aerogels from acidic aqueous solution and chitosan solution in Ionic Liquids (ILs). In addition, chitosan aerogels as drug delivery carriers are introduced in detail and expected to inspire readers to create new kind of drug delivery system based on chitosan aerogels. Finally, growing points and perspectives of chitosan aerogels in drug delivery system are given.
    Matched MeSH terms: Gels/therapeutic use
Related Terms
Contact Us

Please provide feedback to Administrator (tengcl@gmail.com)

External Links